Two studies start simultaneously to verify the toxicological safety profile of SI-053

Today, a pre-clinical toxicological GLP study will start to verify the safety profile of SI-053 in a certified laboratory in Italy. The possibility to conduct this study is a result of a successful pre-study and a fruitful cooperation between two laboratories that developed an administration method that resembles the planned intracerebral administration in humans. The experimental part of the study will take about 3 weeks and the final report with all data evaluated is expected in July. This toxicological study is in accordance with European guidelines for drug development (GLP) and will be